Keros Therapeutics, Inc. (KROS) stock
KROSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.00+0.69 (+6.10%)
Close on Nov 18, 2026Market cap $237.93MP/E –Yield –
Keros Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Keros Therapeutics's market cap was $189.15M on Nov 11, 2026, against $710.25M a year earlier. Over the last 5 years it ranged from $189.15M to $2.27B, with a median of $919.03M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $189.15M | -77.1% |
| 2025 | Dec 31, 2025 | $827.27M | +33.1% |
| 2024 | Dec 31, 2024 | $621.46M | -47.3% |
| 2023 | Dec 29, 2023 | $1.18B | -5.8% |
| 2022 | Dec 30, 2022 | $1.25B | -8.5% |
| 2021 | Dec 31, 2021 | $1.37B | -3.9% |
| 2020 | Dec 31, 2020 | $1.42B | – |
See a number that looks wrong?